Filing Details

Accession Number:
0001127602-23-030394
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-12-22 16:57:12
Reporting Period:
2023-12-20
Accepted Time:
2023-12-22 16:57:12
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1830214 Ginkgo Bioworks Holdings Inc. DNA Biological Products, (No Disgnostic Substances) (2836) 872652913
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1845677 R Jason Kelly C/O Ginkgo Bioworks Holdings
27 Drydock Avenue
Boston MA 02210
See Remarks Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Disposition 2023-12-20 100,000 $1.79 4,194,680 No 4 S Direct
Class A Common Stock Disposition 2023-12-21 100,000 $1.74 4,094,680 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.69 to $1.86, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.70 to $1.785, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.